Dashboard
Manage Tickers

CRNX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

crinetics-randomizes-first-patient-in-phase-3-carefndr-trial-of-oral-paltusotine-for-carcinoid-syndrome
Crinetics Randomizes First Patient In Phas...
11/20/2025 21:11:57

CAREFNDR underscores the potential clinical value of paltusotine beyond acromegaly, and demonstrates progress in Crinetics'...

citizens-maintains-market-outperform-on-crinetics-pharmaceuticals-lowers-price-target-to-108
Citizens Maintains Market Outperform on Cr...
11/07/2025 13:43:22

Citizens analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and lowers the...

crinetics-pharmaceuticals-reports-cash-balance-of-11b-reiterates-cash-burn-of-340-370m-and-cash-runway-into-2029
Crinetics Pharmaceuticals Reports Cash Bal...
11/06/2025 21:41:40

crinetics-pharmaceuticals-q3-eps-138-misses-125-estimate-sales-143000k-miss-363615k-estimate
Crinetics Pharmaceuticals Q3 EPS $(1.38) M...
11/06/2025 21:07:37

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

crinetics-to-present-at-north-american-neuroendocrine-tumor-society-annual-meeting-oct-23-25
Crinetics To Present At North American Neu...
10/23/2025 12:15:54

fastenal-posts-downbeat-earnings-joins-vince-holding-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Fastenal Posts Downbeat Earnings, Joins Vi...
10/13/2025 12:23:05

oppenheimer-maintains-outperform-on-crinetics-pharmaceuticals-raises-price-target-to-87
Oppenheimer Maintains Outperform on Crinet...
09/30/2025 13:46:14

Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price...

morgan-stanley-maintains-overweight-on-crinetics-pharmaceuticals-raises-price-target-to-77
Morgan Stanley Maintains Overweight on Cri...
09/29/2025 17:05:13

Morgan Stanley analyst Jeffrey Hung maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Overweight and raises the pric...

goldman-sachs-maintains-neutral-on-crinetics-pharmaceuticals-raises-price-target-to-40
Goldman Sachs Maintains Neutral on Crineti...
09/26/2025 17:07:48

Goldman Sachs analyst Richard Law maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Neutral and raises the price ta...

fda-approves-crinetics-pharmas-first-daily-pill-for-rare-growth-disorder
FDA Approves Crinetics Pharma's First Dail...
09/26/2025 17:07:40

On Thursday, the U.S.

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/26/2025 17:05:59

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

crinetics-pharmaceuticals-blackberry-perpetua-resources-and-other-big-stocks-moving-higher-on-friday
Crinetics Pharmaceuticals, BlackBerry, Per...
09/26/2025 14:23:15

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceutical...

assessing-crinetics-pharmaceuticals-insights-from-4-financial-analysts
Assessing Crinetics Pharmaceuticals: Insig...
09/26/2025 14:00:57

Throughout the last three months, 4 analysts have evaluated Crinetics Pharmaceuticals (NASDAQ: CRNX), offering a diverse set of...

jmp-securities-maintains-market-outperform-on-crinetics-pharmaceuticals-raises-price-target-to-143
JMP Securities Maintains Market Outperform...
09/26/2025 12:11:56

JMP Securities analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Market Outperform and rai...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/26/2025 12:10:27

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...

trading-halt-halt-status-updated-at-70000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:00:...
09/26/2025 11:00:13

baird-maintains-outperform-on-crinetics-pharmaceuticals-raises-price-target-to-62
Baird Maintains Outperform on Crinetics Ph...
09/26/2025 10:28:09

Baird analyst Brian Skorney maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Outperform and raises the price target...

crinetics-pharmaceuticals-receives-fda-approval-for-palsonify-palsonify-is-expected-to-be-available-in-the-us-in-early-october
Crinetics Pharmaceuticals Receives FDA App...
09/25/2025 21:33:34

SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) today announced that the U.S.

trading-halt-halted-at-51840-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 5:18:40 p.m. ET - ...
09/25/2025 21:18:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION